{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:49:25Z","timestamp":1767422965939},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T00:00:00Z","timestamp":1322611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-499","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T04:55:34Z","timestamp":1322801734000},"source":"Crossref","is-referenced-by-count":9,"title":["Improved blood tests for cancer screening: general or specific?"],"prefix":"10.1186","volume":"11","author":[{"given":"Ian A","family":"Cree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,30]]},"reference":[{"key":"3026_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/0003-4819-149-7-200810070-00004","volume":"149","author":"DA Ahlquist","year":"2008","unstructured":"Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL: Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008, 149: 441-450. W81","journal-title":"Ann Intern Med"},{"key":"3026_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1148\/radiol.2512081235","volume":"251","author":"S Vinnicombe","year":"2009","unstructured":"Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, Dos Santos Silva IM: Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data. Radiology. 2009, 251: 347-358. 10.1148\/radiol.2512081235.","journal-title":"Radiology"},{"key":"3026_CR3","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta15030","volume":"15","author":"HC Kitchener","year":"2011","unstructured":"Kitchener HC, Blanks R, Cubie H, Desai M, Dunn G, Legood R, Gray A, Sadique Z, Moss S, MAVARIC Trial Study Group: MAVARIC: a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Health Technol Assess. 2011, 15: iii-iv. ix-xi, 1-170","journal-title":"Health Technol Assess"},{"key":"3026_CR4","doi-asserted-by":"publisher","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T, Joint European Cohort Study: Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008, 337: a1754-10.1136\/bmj.a1754.","journal-title":"BMJ"},{"key":"3026_CR5","doi-asserted-by":"crossref","unstructured":"Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW: Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst. 103: 520-523.","DOI":"10.1093\/jnci\/djr007"},{"key":"3026_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"68","author":"RC Bast Jr","year":"1981","unstructured":"Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981, 68: 1331-1337. 10.1172\/JCI110380.","journal-title":"J Clin Invest"},{"key":"3026_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","volume":"10","author":"U Menon","year":"2009","unstructured":"Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I: Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009, 10: 327-340. 10.1016\/S1470-2045(09)70026-9.","journal-title":"Lancet Oncol"},{"key":"3026_CR8","first-page":"1518","volume":"20","author":"A Tiss","year":"2011","unstructured":"Tiss A, Timms JF, Smith C, Devetyarov D, Gentry-Maharaj A, Camuzeaux S, Burford B, Nouretdinov I, Ford J, Luo Z, Jacobs I, Menon U, Gammerman A, Cramer R: Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry profiling. Int J Gynecol Cancer. 2011, 20: 1518-1524.","journal-title":"Int J Gynecol Cancer"},{"key":"3026_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nrclinonc.2010.220","volume":"8","author":"SM Hanash","year":"2011","unstructured":"Hanash SM, Baik CS, Kallioniemi O: Emerging molecular biomarkers: blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol. 2011, 8: 142-150. 10.1038\/nrclinonc.2010.220.","journal-title":"Nat Rev Clin Oncol"},{"key":"3026_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA: The Hallmarks of Cancer. Cell. 2000, 100: 57-70. 10.1016\/S0092-8674(00)81683-9.","journal-title":"Cell"},{"issue":"Suppl 3","key":"3026_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","volume":"15","author":"RC Bast Jr","year":"2005","unstructured":"Bast RC, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K: New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005, 15 (Suppl 3): 274-281.","journal-title":"Int J Gynecol Cancer"},{"key":"3026_CR12","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","volume":"70","author":"VM Asiago","year":"2010","unstructured":"Asiago VM, Alvarado LZ, Shanaiah N, Gowda GA, Owusu-Sarfo K, Ballas RA, Raftery D: Early detection of recurrent breast cancer using metabolite profiling. Cancer Res. 2010, 70: 8309-8318. 10.1158\/0008-5472.CAN-10-1319.","journal-title":"Cancer Res"},{"key":"3026_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1593\/neo.81396","volume":"11","author":"S Tiziani","year":"2009","unstructured":"Tiziani S, Lopes V, G\u00fcnther UL: Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia. 2009, 11: 269-276.","journal-title":"Neoplasia"},{"key":"3026_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11481-009-9156-4","volume":"5","author":"A Nordstr\u00f6m","year":"2010","unstructured":"Nordstr\u00f6m A, Lewensohn R: Metabolomics: moving to the clinic. J Neuroimmune Pharmacol. 2010, 5: 4-17. 10.1007\/s11481-009-9156-4.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3026_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/pros.20972","volume":"69","author":"M Johansson","year":"2009","unstructured":"Johansson M, McKay JD, Rinaldi S, Wiklund F, Adami HO, Gr\u00f6nberg H, Kaaks R, Stattin P: Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. Prostate. 2009, 69: 1281-1291. 10.1002\/pros.20972.","journal-title":"Prostate"},{"key":"3026_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4161\/cbt.4.2.1476","volume":"4","author":"A Carbone","year":"2005","unstructured":"Carbone A, Rodeck U, Mauri FA, Sozzi M, Gaspari F, Smirne C, Prati A, Addeo A, Novarino A, Robecchi A, Bertetto O, Emanuelli G, Bellone G: Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response. Cancer Biol Ther. 2005, 4: 231-241. 10.4161\/cbt.4.2.1476.","journal-title":"Cancer Biol Ther"},{"issue":"Suppl 2","key":"3026_CR17","doi-asserted-by":"publisher","first-page":"S359","DOI":"10.1016\/S0753-3322(05)80078-2","volume":"59","author":"T Ueno","year":"2005","unstructured":"Ueno T, Toi M, Linder S: Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother. 2005, 59 (Suppl 2): S359-S362.","journal-title":"Biomed Pharmacother"},{"key":"3026_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000217951","volume":"16","author":"N Inaba","year":"1995","unstructured":"Inaba N, Negishi Y, Fukasawa I, Okajima Y, Ota Y, Tanaka K, Matsui H, Iwasaki H, Sudo H, Tanaka N, Pakk C, Suzuki N, Sekiya S: Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen. Tumor Biol. 1995, 16: 345-352. 10.1159\/000217951.","journal-title":"Tumor Biol"},{"key":"3026_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3109\/1354750X.2010.504308","volume":"15","author":"J Wang","year":"2010","unstructured":"Wang J, Yi Y, Li B, Wang Z, Sun H, Zhang P, Huang W: CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma. Biomarkers. 2010, 15: 594-601. 10.3109\/1354750X.2010.504308.","journal-title":"Biomarkers"},{"key":"3026_CR20","doi-asserted-by":"publisher","first-page":"e7220","DOI":"10.1371\/journal.pone.0007220","volume":"4","author":"Z Chen","year":"2009","unstructured":"Chen Z, Feng J, Buzin CH, Liu Q, Weiss L, Kernstine K, Somlo G, Sommer SS: Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer. PLoS One. 2009, 4: e7220-10.1371\/journal.pone.0007220.","journal-title":"PLoS One"},{"key":"3026_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10549-010-0747-9","volume":"120","author":"RE Board","year":"2011","unstructured":"Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, Donald E, Greystoke A, Ranson M, Hughes A, Dive C: Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast Cancer Res Treat. 2011, 120: 461-467.","journal-title":"Breast Cancer Res Treat"},{"key":"3026_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/ijc.25077","volume":"127","author":"B Dobrzycka","year":"2010","unstructured":"Dobrzycka B, Terlikowski SJ, Mazurek A, Kowalczuk O, Niklinska W, Chyczewski L, Kulikowski M: Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer. Int J Cancer. 2010, 127: 612-621. 10.1002\/ijc.25077.","journal-title":"Int J Cancer"},{"key":"3026_CR23","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/cncr.24893","volume":"116","author":"T Liggett","year":"2010","unstructured":"Liggett T, Melnikov A, Yi QL, Replogle C, Brand R, Kaul K, Talamonti M, Abrams RA, Levenson V: Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010, 116: 1674-1680. 10.1002\/cncr.24893.","journal-title":"Cancer"},{"key":"3026_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1593\/tlo.09256","volume":"3","author":"AS Ho","year":"2003","unstructured":"Ho AS, Huang X, Cao H, Christman-Skieller C, Bennewith K, Le QT, Koong AC: Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol. 2003, 3: 109-113.","journal-title":"Transl Oncol"},{"key":"3026_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4161\/cib.3.5.12693","volume":"3","author":"H Iguchi","year":"2010","unstructured":"Iguchi H, Kosaka N, Ochiya T: Secretory microRNAs as a versatile communication tool. Commun Integr Biol. 2010, 3: 478-481. 10.4161\/cib.3.5.12693.","journal-title":"Commun Integr Biol"},{"key":"3026_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4161\/cib.3.5.12339","volume":"3","author":"A Zomer","year":"2010","unstructured":"Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, Pegtel DM: Exosomes: fit to deliver small RNA. Commun Integr Biol. 2010, 3: 447-450. 10.4161\/cib.3.5.12339.","journal-title":"Commun Integr Biol"},{"key":"3026_CR27","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/cyto.a.20886","volume":"77","author":"AF Orozco","year":"2010","unstructured":"Orozco AF, Lewis DE: Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010, 77: 502-514.","journal-title":"Cytometry A"},{"key":"3026_CR28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1582-4934.2009.00941.x","volume":"14","author":"FTH Wu","year":"2010","unstructured":"Wu FTH, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS: A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med. 2010, 14: 528-552.","journal-title":"J Cell Mol Med"},{"key":"3026_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1615\/CritRevImmunol.v30.i6.30","volume":"30","author":"S Chouaib","year":"2010","unstructured":"Chouaib S, Kieda C, Benlalam H, Noman MZ, Mami-Chouaib F, R\u00fcegg C: Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. Crit Rev Immunol. 2010, 30: 529-545.","journal-title":"Crit Rev Immunol"},{"key":"3026_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ygyno.2009.06.031","volume":"115","author":"DD Taylor","year":"2009","unstructured":"Taylor DD, Gercel-Taylor C, Parker LP: Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol. 2009, 115: 112-120. 10.1016\/j.ygyno.2009.06.031.","journal-title":"Gynecol Oncol"},{"key":"3026_CR31","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-07-0419","volume":"13","author":"T Nakagawa","year":"2007","unstructured":"Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, Hoon DSB: Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res. 2007, 13: 4105-4110. 10.1158\/1078-0432.CCR-07-0419.","journal-title":"Clin Cancer Res"},{"key":"3026_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA: Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008, 14: 985-990. 10.1038\/nm.1789.","journal-title":"Nat Med"},{"key":"3026_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1196\/annals.1448.011","volume":"1137","author":"E Sunami","year":"2008","unstructured":"Sunami E, Vu AT, Nguyen SL, Giuliano AE, Hoon DSB: Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer. Ann N Y Acad Sci. 2008, 1137: 171-174. 10.1196\/annals.1448.011.","journal-title":"Ann N Y Acad Sci"},{"key":"3026_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1258\/acb.2010.009173","volume":"47","author":"VG Moreira","year":"2010","unstructured":"Moreira VG, Prieto B, Rodr\u00edguez JS, Alvarez FV: Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem. 2010, 47: 253-258. 10.1258\/acb.2010.009173.","journal-title":"Ann Clin Biochem"},{"key":"3026_CR35","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","volume":"53","author":"XY Zhong","year":"2007","unstructured":"Zhong XY, von M\u00fchlenen I, Li Y, Kang A, Gupta AK, Tyndall A, Holzgreve W, Hahn S, Hasler P: Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin Chem. 2007, 53: 1609-1614. 10.1373\/clinchem.2006.084509.","journal-title":"Clin Chem"},{"key":"3026_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.7326\/0003-4819-148-9-200805060-00005","volume":"148","author":"PP Glasziou","year":"2008","unstructured":"Glasziou PP, Irwig L, Heritier S, Simes RJ, Tonkin A, LIPID Study Investigators: Monitoring cholesterol levels: measurement error or true change?. Ann Intern Med. 2008, 148: 656-661.","journal-title":"Ann Intern Med"},{"key":"3026_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4240\/wjgs.v2.i4.101","volume":"2","author":"BM K\u00fcnzli","year":"2010","unstructured":"K\u00fcnzli BM, Friess H, Shrikhande SV: Is laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective. World J Gastrointest Surg. 2010, 2: 101-108. 10.4240\/wjgs.v2.i4.101.","journal-title":"World J Gastrointest Surg"},{"key":"3026_CR38","first-page":"CD007334","volume":"2","author":"S Green","year":"2009","unstructured":"Green S, Tawil A, Barr H, Bennett C, Bhandari P, Decaestecker J, Ragunath K, Singh R, Jankowski J: Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev. 2009, 2: CD007334-","journal-title":"Cochrane Database Syst Rev"},{"key":"3026_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/gut.2009.192948","volume":"59","author":"G Hoff","year":"2010","unstructured":"Hoff G, Dominitz JA: Contrasting US and European approaches to colorectal cancer screening: which is best?. Gut. 2010, 59: 407-414. 10.1136\/gut.2009.192948.","journal-title":"Gut"},{"key":"3026_CR40","first-page":"CD001877","volume":"1","author":"PC G\u00f8tzsche","year":"2011","unstructured":"G\u00f8tzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011, 1: CD001877-","journal-title":"Cochrane Database Syst Rev"},{"key":"3026_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","volume":"112","author":"RG Moore","year":"2009","unstructured":"Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, Gajewski W, Kurman R, Bast RC, Skates SJ: A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009, 112: 40-46. 10.1016\/j.ygyno.2008.08.031.","journal-title":"Gynecol Oncol"},{"key":"3026_CR42","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/clpt.2010.245","volume":"88","author":"M Pirmohamed","year":"2010","unstructured":"Pirmohamed M: Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles. Clin Pharmacol Ther. 2010, 88: 862-866. 10.1038\/clpt.2010.245.","journal-title":"Clin Pharmacol Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-499.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-499\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:07:39Z","timestamp":1713157659000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3026"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-499","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,30]]},"article-number":"499"}}